Glucosamine + Chondroitin
424 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
424
Total Reports
25
Deaths Reported
590.0%
Death Rate
Active Ingredients
Glucosamine + Chondroitin
Administration Routes
OralUnknownAuricular (Otic)
Species Affected
Dog 394
Cat 28
Human 2
Most Affected Breeds
Retriever - Labrador 75
Retriever - Golden 30
Crossbred Canine/dog 25
Domestic Shorthair 18
Shepherd Dog - German 12
Shepherd Dog - Australian 11
Pit Bull 10
Boxer (German Boxer) 9
Terrier - Yorkshire 9
Rottweiler 9
Most Reported Reactions
Emesis 89
Vomiting 78
Lethargy (see also Central nervous system depression in 'Neurological') 65
Diarrhoea 35
Lack of efficacy - NOS 32
Other abnormal test result NOS 26
Behavioural disorder NOS 23
Anorexia 21
Weight loss 19
Seizure NOS 17
Not eating 17
Decreased appetite 17
Outcome Breakdown
Recovered/Normal
182 (42.9%)
Outcome Unknown
105 (24.8%)
Ongoing
79 (18.6%)
Recovered with Sequela
33 (7.8%)
Euthanized
16 (3.8%)
Died
9 (2.1%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.